日批在线视频_内射毛片内射国产夫妻_亚洲三级小视频_在线观看亚洲大片短视频_女性向h片资源在线观看_亚洲最大网

Chinadaily.com.cn
 
Go Adv Search

China's mums key to Nestle baby milk deal

Updated: 2012-04-25 11:19

(Agencies)

  Comments() Print Mail Large Medium  Small

LONDON/BEIJING - The rise of the middle-class Chinese working mothers helps explain why Nestle paid nearly $12 billion for Pfizer's baby food business and could leave rivals scrambling to catch up.

Across emerging markets, nowhere more than in China, women are increasingly keeping jobs after having children -- a big driving force behind 10 percent annual growth in the $30 billion a year baby food industry.

Foreign labels such as SMA, Promil and S-26 Gold, which Nestle will get with the Pfizer deal, have a definite edge. Nestle's products include Nan, Gerber, Lactogen and Nestogen, but are less well known in China.

Baby milk was the foundation of the world's biggest food company, established in 1866 when German pharmacist Henri Nestle introduced a substitute for mothers who could not breast-feed.

Paying more for the Pfizer unit than the $10 billion that analysts had expected, Nestle trumped a bid from Danone and Mead Johnson.

The Pfizer nutrition business has 85 percent of its sales in emerging markets, and a quarter of sales in China.

Fuelled by 16 million new births a year, annual growth rates for China's baby formula market have been as high as 20 percent over the last five years. The market is forecast to double to $16 billion by 2016.

"The key strategic attraction of the deal in our view is Pfizer's No 5 position in the Chinese infant formula market where despite being global No 1 player in infant formula, Nestle has a relatively weak presence," said analyst Robert Dickinson at brokers Citi.

The Swiss giant is already market leader in milk formula in Latin America, Africa and the Middle East. This brings it the No 1 spot in Asia with its presence outside China counted too.

Globally, Nestle's baby food market share will rise to 25 percent from 19 percent - although this is likely to fall slightly after sell-offs to ensure regulatory clearance. Mead has 16 percent, Danone 14 percent and Abbott Laboratories 12 percent.

Few options for competitors

The Nestle-Pfizer business in China would only have a combined 12 percent market share behind Mead's leading 16 percent and Danone on 14 percent, but that would still be a rise from 10th place and there may be room for expansion.

Analysts looking at China expect the number of middle class households to double to 100 million by 2015.

主站蜘蛛池模板: 视频在线一区 | 成人午夜视频精品一区 | 久久dvd| 日韩在线 | 亚洲综合一区二区三区 | 久久久91精品 | 天天干狠狠爱 | 欧美激情一区二区三区 | 好吊色在线视频 | a级在线| 欧美视频一二三区 | 国产a精品 | 久久国产中文字幕 | 99热精品在线 | 亚洲一区日韩 | 深夜福利成人 | 午夜精品国产 | xxxx精品| 欧美日韩精品久久久免费观看 | 黄色av地址| 久久久久黄 | 亚洲视频在线看 | 欧美黄色录像 | 欧美经典一区二区三区 | 三级黄色片网站 | 亚洲成人播放 | 久久窝窝| 免费成人在线网站 | 精品视频在线看 | 三星手机最新款 | 亚洲综合网址 | 国产第6页 | 伊人久久久久久久久久 | 三级在线观看视频 | 亚洲免费a| 久久久久女教师免费一区 | 国产一区二区三区视频 | 国产www视频 | 欧美精品1区 | 激情视频久久 | 色网在线 |